(Q41035096)

25 September 2017

Differential myeloma cell responsiveness to interferon-alpha correlates with differential induction of p19(INK4d) and cyclin D2 expression (English)

1 reference

25 September 2017

Arora T

1

1 reference

PubMed ID

9565604

25 September 2017

Jelinek DF

series ordinal

2

1 reference

PubMed ID

9565604

25 September 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

Journal of Biological Chemistry

25 September 2017

1 reference

25 September 2017

273

1 reference

25 September 2017

19

1 reference

25 September 2017

11799-11805

1 reference

Standard treatment of multiple myeloma

25 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.19.11799

Interferons and their actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.19.11799

Plasma cell leukaemia with alpha-interferon therapy in myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.19.11799

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.19.11799

p21 is a universal inhibitor of cyclin kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.19.11799

Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.19.11799

Inhibitors of mammalian G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.19.11799

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.19.11799

A cell cycle regulator potentially involved in genesis of many tumor types

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.19.11799

Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.19.11799

Role of the INK4a locus in tumor suppression and cell mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.19.11799

Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.19.11799

The retinoblastoma protein pathway and the restriction point

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.19.11799

Interferon alpha induces the expression of retinoblastoma gene product in human Burkitt lymphoma Daudi cells: role in growth regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.19.11799

Interferons and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.19.11799

Interferon modulates the messenger RNA of G1-controlling genes to suppress the G1-to-S transition in Daudi cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.19.11799

Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-alpha in hematopoietic cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.19.11799

A role for the cyclin-dependent kinase inhibitor p21 in the G1 cell cycle arrest mediated by the type I interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.19.11799

Differential human multiple myeloma cell line responsiveness to interferon-alpha. Analysis of transcription factor activation and interleukin 6 receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.19.11799

Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.19.11799

Functional analysis of the human cyclin D2 and cyclin D3 promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.19.11799

Induction of p18INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.19.11799

Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.19.11799

Double-stranded RNA-dependent protein kinase mediates c-Myc suppression induced by type I interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.19.11799

Development of aggressive plasma cell leukaemia under interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.19.11799

Alterations of the p15, p16,and p18 genes in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.19.11799

Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.19.11799

21 January 2018

Identifiers

DOI

10.1074/JBC.273.19.11799

1 reference

25 September 2017

1 reference

PubMed ID

9565604